Docket Room
SB 351·AL·senate

Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded

FailedFiled Mar 10, 2026
Sponsor: April Weaver (R)
Latest Action

Currently Indefinitely Postponed

Apr 7, 2026

Summary

The legislation expands the kinds of single‑dose epinephrine that students may carry and that schools may stock and administer, allowing any FDA‑approved pre‑measured form. It applies to public and non‑public schools, other authorized entities, and staff members who are trained to handle anaphylaxis. The change aims to increase access to life‑saving medication for students with severe allergies.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when SB 351 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice